4Suzuki M, Hirono M, Majlma H. Cardiotoxicity due to prolonged administration of THP (2"R-4'O-tetrahydropyranyl-adriamycin). Gan To Kagaku Ryoho, 1997,24 : 1993.
5Culy CR,Spencer CM.Amifostine:an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome[J].Drugs,2001,61(5):641-684.
6Lynn M,Schuchter ML,Hensley,NJ.et al.2002 update of recommendations for the use of chemotherapy and radiotherapy protectants:clinical practice guidelines of the american society of clinical oncology[J].J Clin Oncol,2002,20(12):2895-2903.
7List AF.Use of amifostine in hematologic malignancies,myelodysplastic syndrome,and acute leukemia[J].Semin Oncol,1999,26 (2 Suppl7):61-65.
8Estey E. Treatment of refractory AML [ J ]. Leukemia , 1996,10 : 932-936